{{Rsnum
|rsid=9322336
|Gene=ESR1
|Chromosome=6
|position=151879295
|Orientation=plus
|GMAF=0.2287
|Gene_s=ESR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 39.8 | 58.4
| HCB | 15.3 | 54.7 | 29.9
| JPT | 20.4 | 50.4 | 29.2
| YRI | 0.0 | 0.0 | 100.0
| ASW | 1.8 | 7.0 | 91.2
| CHB | 15.3 | 54.7 | 29.9
| CHD | 16.5 | 43.1 | 40.4
| GIH | 13.9 | 46.5 | 39.6
| LWK | 0.0 | 0.0 | 0.0
| MEX | 8.6 | 34.5 | 56.9
| MKK | 0.0 | 1.3 | 98.7
| TSI | 9.8 | 29.4 | 60.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23546553
|Title=Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer
|OA=1
}}

{{PMID Auto
|PMID=19543528
|Title=Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}